Dae Joong Im

Title: Dae Joong Im: Innovator in Pain and Anxiety Treatment

Introduction

Dae Joong Im is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pain, anxiety, and depression. With a total of 3 patents to his name, his work is recognized for its innovative approach to mental health and pain management.

Latest Patents

Dae Joong Im's latest patents include a method for treating pain, anxiety, or depression using a carbamoyloxy alkanoyl piperazine compound. This novel compound is characterized by its abundant racemic or enantiomeric properties, represented by a specific formula. The patent outlines a pharmaceutical composition that includes an effective amount of this compound, along with a method for administering it to mammals in need of treatment. Another significant patent focuses on carbamoyloxy arylalkan arylpiperazine analgesics, which also emphasizes the compound's potential in treating similar conditions.

Career Highlights

Dae Joong Im is currently associated with SK Biopharmaceuticals Co., Ltd., where he continues to develop innovative solutions in the pharmaceutical industry. His work has garnered attention for its potential to improve the quality of life for individuals suffering from various mental health issues and chronic pain.

Collaborations

Throughout his career, Dae Joong Im has collaborated with notable colleagues, including Eun Hee Chae and Ki Ho Lee. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.

Conclusion

Dae Joong Im's contributions to the field of pharmaceuticals highlight his commitment to addressing critical health issues through innovation. His patents reflect a deep understanding of the complexities of pain and mental health, positioning him as a key figure in the ongoing quest for effective treatments.